Weibond Technology Global Product Release: The First World Class Pharmacy Robotic Compounding System from China
ANAHEIM, Calif., Dec. 4, 2018
ANAHEIM, Calif., Dec. 4, 2018 /PRNewswire/ -- Weibond Technology, established in 2009, is a robotic technology innovator in IV compounding automation. Our vision is to revolutionize the way pharmacists and nurses do sterile IV compounding through reliable, innovative robotic technology while improving the quality of life for patients and caregivers in the global healthcare community.
Weibond Technology is the first world-class medical equipment manufacturing and services company from China to exhibit at American Society of Health-System Pharmacists Midyear Clinical Exhibition December 3-5, 2018. The company is making its global debut of the Weinas (Weibond Intravenous Assistant System) product line. Two automated robotic system models are exhibited:
- WEINAS PD-160 Series – Compatible with both Vials and Ampoule drug containers
- WEINAS VD-160 Series – Vials Compatible
Operational demonstrations will be conducted on site to professional pharmacists and industry professionals from all over the world.
These systems represent 10 years of research and development, along with over 2 years of successful clinical hospital application at several institutions in China. Developed entirely in China, and granted over 150 patents, the company's robotic IV drug compounding systems offer patient and occupational safety, accountable accuracy recording, compounding speed, and cost efficiency. WEINAS Compounding Robots are the solution for Hospital Pharmacies and Medical Compounding Operations.
Clinical Study Outcomes
- 1-5 minutes per IV bag per patient
- 54.72 ~ 57.84 sec per vial or ampoule
- Drug compatibility: 95.77%
- ZERO occupational injury due to needles / glass
- 0% Failure on Vials
- 0.026% Failure on Ampoules (mostly glass quality)
About Weibond Technology
Weibond Technology was founded in 2009 and is one of the pioneers and leaders of China's medical equipment manufacturers. Their world-class WEINAS Robotic IV Compounding Systems have been in clinical use since early 2016. Their success enables the company to now enter the global market, and the company is bringing their full range of WEINAS intelligent IV drug compounding robots to ASHP, the top event in the global pharmaceutical field. Operational demonstrations will be conducted on site to professional pharmacists and industry professionals from all over the world.
With 372 companies participating in the ASHP exhibition, Weibond is the only Chinese company in attendance, showing the first world class pharmacy robotic compounding system from China ever at ASHP. Weibond is also a Silver Sponsor of this exhibition.
For more information about Weibond Technology, please visit www.weibond.com
Richard Zhou SVP
+1 310 933 7089
+86 1391 050 8400
SOURCE Weibond Technology